Biological Testing Facility
The National Institute of Child Health and Human Development (NICHD), part of the National Institutes of Health under the Department of Health and Human Services, is seeking proposals for an Indefinite Delivery, Indefinite Quantity (IDIQ) contract to establish and operate a Biological Testing Facility (BTF) that will provide preclinical research and development services for fertility management, reproductive health, and therapeutic products. Services include in vitro and in vivo assays, efficacy evaluations, safety and toxicology assessments, ADME/DMPK profiling, formulation development, GMP clinical batch manufacturing, animal care services, and database management. Offerors must possess Good Manufacturing Practices (GMP) and Good Laboratory Practice (GLP) certification, maintain in-house facilities for animal care and non-human primate housing, hold FDA Drug Establishment Registration, and comply with extensive federal security and privacy requirements including FISMA compliance and NIST standards. The evaluation will assess technical merit, research rigor, consideration of sex as biological variables, data management plans, past performance on similar contracts, and cost-reimbursement proposals. Proposals are due by 4:00 PM Eastern Time on May 28, 2026, with award anticipated on or about September 30, 2026.
This is a competitive acquisition with no small business set-aside, though HUBZone small business concerns may receive evaluation preferences. The contract carries a minimum value of $100,000 and a maximum value of $49,000,000 over an eight-year performance period from September 30, 2026, through September 29, 2033. One IDIQ contract is anticipated to be awarded concurrently with the Management, Administration, and Database task order and two initial task orders addressing administrative functions and reproductive health research. Work will be performed at NICHD facilities in Bethesda, Maryland, with all deliverables submitted via the NICHD Contracts Portal. Contractors must register in the System for Award Management (SAM.gov), submit detailed technical and business proposals with cost breakdowns, and acknowledge receipt of all amendments, with the most recent amendment (Amendment 0003) issued on April 28, 2026, providing clarifications regarding proposal page limitations and the Reproductive Health Task Order requirements.
75N94026R00005 Department of Health and Human Services National Institutes of Health National Institute of Child Health and Human Development
4/13/26, 4:57 PM Pre-Solicitation Notice
The National Institute of Child Health and Human Development (NICHD), a division of the National Institutes of Health, is seeking a contractor to establish and operate a state-of-the-art Biological Testing Facility to support the NIH's Contraceptive Development Program. The primary services include conducting in vitro enzymatic and cell-based assays, in vivo studies, anti-fertility assessments, endocrine activity evaluations, toxicity testing, formulation and stability studies, ADME profiling, and DMPK profiling of new chemical compounds, delivery systems, and devices. The contractor must demonstrate expertise in drug evaluation across multiple animal species including rodents, rabbits, and non-human primates, and provide comprehensive preclinical development support including process and product development, clinical lot production, subcontractor management, and IND application preparation and FDA submission support. The formal solicitation (RFP 75N94026R00005) will be released on or about April 13, 2026, with proposals due on or about May 28, 2026, and all submissions must be made electronically through SAM.gov. Prospective bidders must be registered in the System for Award Management database to be eligible for contract award, and inquiries may be directed to Sean Dunn (Contract Specialist) or Gannon White (Contracting Officer) at the NIH's Research and Development and Professional Services division in Bethesda, Maryland.
This procurement is structured as a single Indefinite-Delivery, Indefinite-Quantity cost-reimbursement contract with a seven-year ordering period beginning on or around September 30, 2026, and no set-aside designations apply. The notice does not identify any current incumbent contractor or provide a specific award value or budget range. The solicitation will be conducted through full and open competition under NAICS code 541715 (Research and Development in the Physical, Engineering, and Life Sciences), making this opportunity available to qualified private sector contractors capable of meeting the technical and operational requirements outlined by NICHD.
75N94026R00005 Department of Health and Human Services National Institutes of Health National Institute of Child Health and Human Development
3/27/26, 1:39 PM